Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 337

1.

Circulating inflammation-related markers and advanced gastric premalignant lesions.

Song M, Rabkin CS, Torres J, Kemp TJ, Zabaleta J, Pinto LA, Hildesheim A, Sánchez-Figueroa L, Guarner J, Herrera-Goepfert R, Parsonnet J, Camargo MC.

J Gastroenterol Hepatol. 2018 Oct 24. doi: 10.1111/jgh.14518. [Epub ahead of print]

PMID:
30357905
2.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
3.

Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.

Purdue MP, Lan Q, Hoffman-Bolton J, Hildesheim A, Callahan CL, Strickland P, Visvanathan K, Rothman N.

Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31879. [Epub ahead of print]

PMID:
30230539
4.

Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.

Song M, Sasazuki S, Camargo MC, Shimazu T, Charvat H, Yamaji T, Sawada N, Kemp TJ, Pfeiffer RM, Hildesheim A, Pinto LA, Rabkin CS, Tsugane S.

Int J Cancer. 2018 Dec 1;143(11):2767-2776. doi: 10.1002/ijc.31821. Epub 2018 Oct 9.

PMID:
30132835
5.

Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.

Cook MB, Barnett MJ, Bock CH, Cross AJ, Goodman PJ, Goodman GE, Haiman CA, Khaw KT, McCullough ML, Newton CC, Boutron-Ruault MC, Lund E, Rutegård M, Thornquist MD, Spriggs M, Giffen C, Freedman ND, Kemp T, Kroenke CH, Le Marchand L, Park JY, Simon M, Wilkens LR, Pinto L, Hildesheim A, Campbell PT.

Gut. 2018 Aug 18. pii: gutjnl-2018-316678. doi: 10.1136/gutjnl-2018-316678. [Epub ahead of print]

6.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

PMID:
30099516
7.

Distribution of dysplasia and cancer in the gallbladder: an analysis from a high cancer-risk population.

Koshiol J, Bellolio E, Vivallo C, Cook P, Roa JC, McGee EE, Losada H, Van Dyke AL, Van De Wyngard V, Prado R, Villaseca M, Riquelme P, Acevedo J, Olivo V, Pettit K, Hildesheim A, Medina K, Memis B, Adsay V, Ferreccio C, Araya JC.

Hum Pathol. 2018 Dec;82:87-94. doi: 10.1016/j.humpath.2018.07.015. Epub 2018 Jul 21.

PMID:
30036595
8.

Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.

Coghill AE, Hsu WL, Yang Q, Wang CP, Lou PJ, Yu KJ, Yu G, Diehl SR, Chen CJ, Goldstein AM, Hildesheim A.

J Gen Virol. 2018 Sep;99(9):1268-1273. doi: 10.1099/jgv.0.001115. Epub 2018 Jul 5.

PMID:
29975184
9.

Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.

Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D; Costa Rica HPV Vaccine Trial and the PATRICIA study groups .

J Infect Dis. 2018 Jun 5;218(1):84-94. doi: 10.1093/infdis/jiy112.

PMID:
29718393
10.

Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.

Coghill AE, Bu W, Hsu WL, Nguyen H, Yu KJ, Chien YC, Chen CJ, Cohen JI, Hildesheim A.

J Infect Dis. 2018 Aug 14;218(6):886-891. doi: 10.1093/infdis/jiy250.

PMID:
29718378
11.

Association of circulating inflammation proteins and gallstone disease.

Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Wang B, Shen MC, Rashid A, Hsing AW, Hildesheim A, Pfeiffer RM, Pinto LA, Koshiol J.

J Gastroenterol Hepatol. 2018 Nov;33(11):1920-1924. doi: 10.1111/jgh.14265. Epub 2018 May 17.

PMID:
29671891
12.

Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer.

Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Roa JC, Wang B, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA, Koshiol J.

Sci Rep. 2018 Apr 4;8(1):5671. doi: 10.1038/s41598-018-23848-8.

13.

Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.

Koshiol J, Gao YT, Corbel A, Kemp TJ, Shen MC, Hildesheim A, Hsing AW, Rashid A, Wang B, Pfeiffer RM, Pinto LA.

Cancer Epidemiol. 2018 Jun;54:25-30. doi: 10.1016/j.canep.2018.03.004. Epub 2018 Mar 16.

PMID:
29554539
14.

Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.

Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, Doolan DL, Hildesheim A.

J Infect Dis. 2018 May 25;217(12):1923-1931. doi: 10.1093/infdis/jiy122.

PMID:
29509907
15.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

PMID:
29499070
16.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

17.

An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.

Beachler DC, Pinto LA, Kemp TJ, Nyitray AG, Hildesheim A, Viscidi R, Schussler J, Kreimer AR, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):496-502. doi: 10.1158/1055-9965.EPI-17-0853. Epub 2018 Feb 23.

PMID:
29475967
18.

Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.

Sampson JN, Hildesheim A, Herrero R, Gonzalez P, Kreimer AR, Gail MH.

Contemp Clin Trials. 2018 May;68:35-44. doi: 10.1016/j.cct.2018.02.010. Epub 2018 Feb 21.

PMID:
29474934
19.

Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention.

Koshiol J, Liu Z, O'Brien TR, Hildesheim A.

Cancer Epidemiol. 2018 Apr;53:195-199. doi: 10.1016/j.canep.2018.01.007. Epub 2018 Feb 13. Review.

PMID:
29396075
20.

T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.

Lang Kuhs KA, Lin SW, Hua X, Schiffman M, Burk RD, Rodriguez AC, Herrero R, Abnet CC, Freedman ND, Pinto LA, Hamm D, Robins H, Hildesheim A, Shi J, Safaeian M.

PLoS One. 2018 Jan 31;13(1):e0178167. doi: 10.1371/journal.pone.0178167. eCollection 2018.

21.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782. doi: 10.1016/j.vaccine.2017.12.078. Epub 2018 Feb 1.

22.

Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.

Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ PhD, Lou PJ MD, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL.

Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4.

PMID:
29301829
23.

FIVE AUTHORS REPLY.

Chang ET, Liu Z, Hildesheim A, Adami HO, Ye W.

Am J Epidemiol. 2018 Feb 1;187(2):399. doi: 10.1093/aje/kwx352. No abstract available.

PMID:
29126104
24.

Industrial hog farming is associated with altered circulating immunological markers.

Hofmann JN, Shiels MS, Friesen MC, Kemp TJ, Chaturvedi AK, Lynch CF, Parks CG, Pinto LA, Hildesheim A, Alavanja MCR, Beane Freeman LE.

Occup Environ Med. 2018 Mar;75(3):212-217. doi: 10.1136/oemed-2017-104519. Epub 2017 Oct 21.

PMID:
29055885
25.

A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.

Shiels MS, Shu XO, Chaturvedi AK, Gao YT, Xiang YB, Cai Q, Hu W, Shelton G, Ji BT, Pinto LA, Kemp TJ, Rothman N, Zheng W, Hildesheim A, Lan Q.

Carcinogenesis. 2017 Oct 1;38(10):1004-1010. doi: 10.1093/carcin/bgx075.

26.

Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in China.

Bassig BA, Dai Y, Vermeulen R, Ren D, Hu W, Duan H, Niu Y, Xu J, Shiels MS, Kemp TJ, Pinto LA, Fu W, Meliefste K, Zhou B, Yang J, Ye M, Jia X, Meng T, Wong JYY, Bin P, Hosgood HD 3rd, Hildesheim A, Silverman DT, Rothman N, Zheng Y, Lan Q.

Carcinogenesis. 2017 Oct 26;38(11):1104-1111. doi: 10.1093/carcin/bgx081.

27.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.

Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx158.

28.

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.

Lang Kuhs KA, Kreimer AR, Trivedi S, Holzinger D, Pawlita M, Pfeiffer RM, Gibson SP, Schmitt NC, Hildesheim A, Waterboer T, Ferris RL.

Cancer. 2017 Nov 15;123(22):4382-4390. doi: 10.1002/cncr.30966. Epub 2017 Sep 26.

29.

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, Steinberg M, Burdett L, Dean M, Roberson D, Mitchell J, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, Kreimer AR, Beachler DC, Hildesheim A, Gonzalez P, Porras C, Burk RD, Schiffman M.

Cell. 2017 Sep 7;170(6):1164-1174.e6. doi: 10.1016/j.cell.2017.08.001.

30.

Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.

Coghill AE, Wang CP, Verkuijilen SAWM, Yu KJ, Hsu WL, Middeldorp JM, Hildesheim A.

J Med Virol. 2018 Jan;90(1):191-195. doi: 10.1002/jmv.24918. Epub 2017 Sep 11.

PMID:
28833336
31.

Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2017 Aug 14;13(8):e1006866. doi: 10.1371/journal.pgen.1006866. eCollection 2017 Aug. Erratum in: PLoS Genet. 2018 Mar 1;14 (3):e1007257.

32.

Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.

Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M.

PLoS One. 2017 Jul 28;12(7):e0182359. doi: 10.1371/journal.pone.0182359. eCollection 2017.

33.

The Natural History of Oral Human Papillomavirus in Young Costa Rican Women.

Beachler DC, Lang Kuhs KA, Struijk L, Schussler J, Herrero R, Porras C, Hildesheim A, Cortes B, Sampson J, Quint W, Gonzalez P, Kreimer AR.

Sex Transm Dis. 2017 Jul;44(7):442-449. doi: 10.1097/OLQ.0000000000000625.

34.

Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.

Correia S, Palser A, Elgueta Karstegl C, Middeldorp JM, Ramayanti O, Cohen JI, Hildesheim A, Fellner MD, Wiels J, White RE, Kellam P, Farrell PJ.

J Virol. 2017 Jul 12;91(15). pii: e00375-17. doi: 10.1128/JVI.00375-17. Print 2017 Aug 1.

35.

Active and Passive Smoking and Risk of Nasopharyngeal Carcinoma: A Population-Based Case-Control Study in Southern China.

Chang ET, Liu Z, Hildesheim A, Liu Q, Cai Y, Zhang Z, Chen G, Xie SH, Cao SM, Shao JY, Jia WH, Zheng Y, Liao J, Chen Y, Lin L, Ernberg I, Vaughan TL, Adami HO, Huang G, Zeng Y, Zeng YX, Ye W.

Am J Epidemiol. 2017 Jun 15;185(12):1272-1280. doi: 10.1093/aje/kwx018.

36.

Association of Aflatoxin and Gallbladder Cancer.

Koshiol J, Gao YT, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke AL, Ferreccio C, Malasky M, Shen MC, Zhu B, Andersen JB, Hildesheim A, Hsing AW, Groopman J.

Gastroenterology. 2017 Aug;153(2):488-494.e1. doi: 10.1053/j.gastro.2017.04.005. Epub 2017 Apr 17.

37.

Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx005.

38.

A cross-sectional study of changes in markers of immunological effects and lung health due to exposure to multi-walled carbon nanotubes.

Vlaanderen J, Pronk A, Rothman N, Hildesheim A, Silverman D, Hosgood HD, Spaan S, Kuijpers E, Godderis L, Hoet P, Lan Q, Vermeulen R.

Nanotoxicology. 2017 Apr;11(3):395-404. doi: 10.1080/17435390.2017.1308031. Epub 2017 Apr 3.

PMID:
28301273
39.

Impact of freeze-thaw cycles on circulating inflammation marker measurements.

Huang WY, Kemp TJ, Pfeiffer RM, Pinto LA, Hildesheim A, Purdue MP.

Cytokine. 2017 Jul;95:113-117. doi: 10.1016/j.cyto.2017.02.016. Epub 2017 Mar 3.

PMID:
28260648
40.

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection.

Beachler DC, Waterboer T, Pierce Campbell ChM, Ingles DJ, Kuhs KA, Nyitray AG, Hildesheim A, Pawlita M, Kreimer AR, Giuliano AR.

Papillomavirus Res. 2016 Dec;2:141-144. doi: 10.1016/j.pvr.2016.07.003. Epub 2016 Jul 28.

41.

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.

Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WAJ, Porras C, Quint W, Rodriguez AC, Schiffman M, Schussler J, Skinner SR, Teixeira JC, Wheeler CM, Herrero R, Hildesheim A, Lehtinen M; Costa Rica Vaccine Trial and the PATRICIA study groups.

J Natl Cancer Inst. 2017 Jan 28;109(7). doi: 10.1093/jnci/djw300. Print 2017 Jan.

42.

Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.

Rodríguez AC, Ávila C, Herrero R, Hildesheim A, Sherman ME, Burk RD, Morales J, Alfaro M, Guillén D, Trejos ME, Vargas RM, Torres G, Schiffman M.

Int J Cancer. 2017 Apr 15;140(8):1926-1934. doi: 10.1002/ijc.30614. Epub 2017 Feb 7.

43.

Trends in cervical cancer incidence in younger US women from 2000 to 2013.

Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS.

Gynecol Oncol. 2017 Feb;144(2):391-395. doi: 10.1016/j.ygyno.2016.11.031. Epub 2016 Nov 26.

44.

Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation.

Van Dyke AL, Kemp TJ, Corbel AF, Zhu B, Gao YT, Wang BS, Rashid A, Shen MC, Hildesheim A, Hsing AW, Pinto LA, Koshiol J.

Ann Epidemiol. 2016 Oct;26(10):704-709. doi: 10.1016/j.annepidem.2016.08.009. Epub 2016 Aug 31.

45.

Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N.

Int J Cancer. 2017 Feb 1;140(3):600-610. doi: 10.1002/ijc.30478. Epub 2016 Nov 7.

46.

Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan.

Liu Z, Coghill AE, Pfeiffer RM, Hsu WL, Lou PJ, Wang CP, Yu KJ, Niwa S, Brotzman M, Ye W, Chen CJ, Hildesheim A.

Int J Cancer. 2016 Dec 1;139(11):2467-73. doi: 10.1002/ijc.30390. Epub 2016 Aug 30.

47.

Partial Least Square Discriminant Analysis Discovered a Dietary Pattern Inversely Associated with Nasopharyngeal Carcinoma Risk.

Lo YL, Pan WH, Hsu WL, Chien YC, Chen JY, Hsu MM, Lou PJ, Chen IH, Hildesheim A, Chen CJ.

PLoS One. 2016 Jun 1;11(6):e0155892. doi: 10.1371/journal.pone.0155892. eCollection 2016.

48.

Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies.

Koshiol J, Castro F, Kemp TJ, Gao YT, Roa JC, Wang B, Nogueira L, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA.

Cytokine. 2016 Jul;83:217-225. doi: 10.1016/j.cyto.2016.05.003. Epub 2016 May 9.

49.

High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.

Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI.

Clin Cancer Res. 2016 Jul 15;22(14):3451-7. doi: 10.1158/1078-0432.CCR-15-2299. Epub 2016 Feb 26.

50.

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.

Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R; Costa Rica HPV Vaccine Trial (CVT) Group.

Am J Obstet Gynecol. 2016 Aug;215(2):212.e1-212.e15. doi: 10.1016/j.ajog.2016.02.021. Epub 2016 Feb 16.

Supplemental Content

Loading ...
Support Center